Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol

Low-density lipoprotein cholesterol (LDL-C) is a modifiable risk factor for the development of atherosclerotic cardiovascular disease. Statins have been the gold standard for managing cholesterol levels and reducing the risks associated with atherosclerotic cardiovascular disease; however, many pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Bardolia, Chandni, Amin, Nishita Shah, Turgeon, Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635697/
https://www.ncbi.nlm.nih.gov/pubmed/34869702
http://dx.doi.org/10.3389/fcvm.2021.789931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635697/
https://www.ncbi.nlm.nih.gov/pubmed/34869702
http://dx.doi.org/10.3389/fcvm.2021.789931

Ejemplares similares